Interventional Cardiology Devices Market By Product (Coronary Stents, Catheters, Plaque Modification Devices, Structural Heart Devices, Angioplasty Stents), End User (Hospitals & ASCs, Catheterization Labs), & Region for 2024-2031

Interventional Cardiology Devices Market Valuation – 2024-2031

Rising preference for minimally invasive procedures is propelling the adoption of Interventional Cardiology Devices. Growing Prevalence of Cardiovascular Diseases is a major factor. CVDs, including coronary artery disease (CAD), are becoming increasingly common worldwide is driving the market size to surpass USD 18.43 Billion valued in 2023 to reach a valuation of around USD 33.49 Billion by 2031.

In addition to this, Continuous advancements in interventional cardiology devices are making them more effective, less invasive, and easier to use is spurring up the adoption of Interventional Cardiology Devices. Rising government spending on cardiovascular diseases is enabling the market grow at a CAGR of 8.55% from 2024 to 2031.

Interventional Cardiology Devices MarketDefinition/ Overview

Interventional cardiology devices encompass a wide range of medical instruments, tools, and implants designed for use in minimally invasive procedures to diagnose and treat cardiovascular diseases. These devices are typically deployed through catheters inserted into blood vessels, enabling cardiologists to access the heart and surrounding vasculature without the need for open surgery. Interventional cardiology procedures are performed in specialized catheterization labs, often referred to as “cath labs.”

PCI procedures, also known as coronary angioplasty with stenting, involve the use of interventional cardiology devices to treat coronary artery disease by removing plaque buildup and improving blood flow to the heart. PCI procedures are used to treat conditions such as angina, myocardial infarction (heart attack), and acute coronary syndromes. Interventional cardiology devices are employed in the treatment of peripheral artery disease (PAD) and other vascular conditions affecting the arteries and veins outside the heart. These procedures may include balloon angioplasty, atherectomy, thrombectomy, and the placement of stents or drug-coated balloons to restore blood flow in the peripheral vasculature.

The future of interventional cardiology devices lies in technological innovations aimed at enhancing procedural outcomes, improving patient safety, and expanding the scope of minimally invasive interventions. Advances in device materials, design, imaging technology, and navigation systems will enable cardiologists to perform more complex procedures with greater precision and efficiency.

How Will Rising Prevalence of Cardiovascular Disease Increase Adoption of Interventional Cardiology Devices?

The high prevalence of cardiovascular diseases, such as coronary artery disease, heart failure, and structural heart defects, is a significant driver of the Interventional Cardiology Devices Market. As cardiovascular diseases remain a leading cause of morbidity and mortality worldwide, there is a growing demand for minimally invasive treatment options provided by interventional cardiology devices.

Also, Continuous innovation and advancements in interventional cardiology devices drive market growth. Manufacturers invest in research and development to develop next-generation devices with improved efficacy, safety, and ease of use. Technological advancements include the development of drug-eluting stents, bioresorbable scaffolds, transcatheter heart valves, and intravascular imaging systems, among others, which expand treatment options and improve patient outcomes.

In addition to this, there is a global trend towards minimally invasive procedures in cardiology, driven by benefits such as reduced patient morbidity, shorter hospital stays, quicker recovery times, and lower healthcare costs. Interventional cardiology devices enable cardiologists to perform complex procedures through small incisions or catheter-based approaches, replacing traditional open-heart surgery in many cases.

Also, increasing healthcare expenditure, particularly in emerging markets, drives market growth by expanding access to interventional cardiology procedures and devices. Governments, healthcare providers, and insurance companies invest in improving healthcare infrastructure, increasing awareness about cardiovascular diseases, and expanding reimbursement policies, leading to greater adoption of interventional cardiology devices.

Will High Cost of Devices and Procedures of Interventional Cardiology Devices Restrain Its Application?

Interventional cardiology devices, such as drug-eluting stents, transcatheter heart valves, and intravascular imaging systems, can be expensive. Additionally, the cost of interventional cardiology procedures, including hospitalization, physician fees, and ancillary services, can be substantial. High costs may limit patient access to advanced interventional treatments, particularly in regions with limited healthcare resources or inadequate insurance coverage.

Also, Despite advancements in device technology and procedural techniques, interventional cardiology procedures carry inherent risks of complications and adverse events, including stent thrombosis, restenosis, vascular injury, bleeding, and infection. The occurrence of such events can undermine patient confidence in interventional treatments and lead to reluctance among healthcare providers to adopt new devices or perform complex procedures, particularly in high-risk patient populations.

In addition to this, Market consolidation among healthcare providers, group purchasing organizations (GPOs), and integrated delivery networks (IDNs) can exert pricing pressure on device manufacturers, leading to lower reimbursement rates and tighter profit margins. Manufacturers may face challenges in maintaining pricing competitiveness while investing in research and development to innovate new devices and comply with regulatory requirements, potentially limiting investment in the interventional cardiology market.

Category-Wise Acumens

Will Rise in Adoption of Coronary Stents Drive Interventional Cardiology Devices Market?

The coronary stent is dominating Interventional Cardiology Devices Market. Coronary artery disease (CAD) is one of the most common cardiovascular conditions globally, affecting millions of people each year. CAD occurs due to the buildup of plaque (atherosclerosis) in the coronary arteries, leading to narrowing or blockage of blood flow to the heart. Coronary stents are extensively used in the treatment of CAD to open blocked arteries and restore blood flow to the heart muscle.

Also, percutaneous coronary intervention (PCI), commonly known as coronary angioplasty, is a primary treatment modality for CAD. During PCI, a coronary stent is inserted into the narrowed or blocked artery to keep it open and prevent restenosis (re-narrowing) after balloon angioplasty. The high prevalence of CAD and the widespread adoption of PCI procedures contribute to the dominance of coronary stents in the Interventional Cardiology Devices Market.

In addition to this, Coronary stent technology has evolved significantly over the years, leading to the development of various types of stents, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable scaffolds (BRS). Drug-eluting stents, in particular, release medication to prevent scar tissue formation and reduce the risk of restenosis, making them the preferred choice in most cases.

Furthermore, the coronary stent market is highly competitive, with several key players competing to develop innovative stent designs, drug-eluting technologies, and bioresorbable materials. Manufacturers invest heavily in research and development to enhance stent deliverability, biocompatibility, and long-term safety and efficacy profiles. This continuous innovation drives market growth and maintains the dominance of coronary stents in the Interventional Cardiology Devices Market.

Which Factors Contributing Hospitals & ASCs Segment Growth in Interventional Cardiology Devices Market?

Hospitals, especially large tertiary care centers and cardiac specialty hospitals, perform a significant volume of interventional cardiology procedures compared to other healthcare settings. They have dedicated catheterization labs equipped with advanced imaging systems, interventional devices, and experienced medical teams, enabling them to handle complex cases and high patient volumes.

Also, Hospitals offer comprehensive cardiac care services, including emergency interventions, diagnostic procedures, elective interventions, and post-procedural care. They have the infrastructure, resources, and expertise to manage a wide range of cardiovascular conditions, from acute myocardial infarction to structural heart defects, peripheral vascular disease, and arrhythmias.

In addition to this, Hospitals employ multidisciplinary teams of cardiologists, interventionalists, cardiac surgeons, nurses, and support staff who collaborate to deliver integrated care and personalized treatment plans for patients with complex cardiac conditions. This multidisciplinary approach ensures continuity of care and optimal patient outcomes.

Furthermore, Hospitals attract highly skilled and specialized healthcare professionals, including interventional cardiologists, cardiac surgeons, electrophysiologists, and cardiovascular imaging specialists. These experts have extensive training and experience in performing interventional procedures and managing complex cardiovascular conditions, making hospitals the preferred choice for patients seeking advanced cardiac care.

Gain Access to Interventional Cardiology Devices Market Report Methodology

Country/Region-wise Acumens

Will Advanced Healthcare Infrastructure in North America Mature Interventional Cardiology Devices Market?

North America boasts a highly developed healthcare infrastructure, with state-of-the-art medical facilities, advanced technology, and a skilled workforce. The region is home to numerous leading hospitals, academic medical centers, and specialty cardiac care centers equipped with catheterization labs and interventional cardiology suites.

Also, Cardiovascular diseases, including coronary artery disease, heart failure, and arrhythmias, are major health concerns in North America, accounting for a significant burden of morbidity, mortality, and healthcare expenditure. The prevalence of risk factors such as obesity, hypertension, diabetes, and sedentary lifestyle contributes to the high incidence of cardiovascular diseases in the region.

In addition to this, North America is a global hub for medical device innovation, with many leading interventional cardiology device manufacturers headquartered in the United States and Canada. These companies invest heavily in research and development to develop cutting-edge devices, including coronary stents, angioplasty balloons, structural heart devices, and intravascular imaging systems, driving technological advancements and market growth.

Will Increasing Prevalence of Cardiovascular Diseases in Asia Pacific Enhance Adoption of Interventional Cardiology Devices?

Cardiovascular diseases (CVDs) are a growing public health concern in Asia Pacific, fueled by urbanization, sedentary lifestyles, dietary changes, and aging populations. Conditions such as coronary artery disease, hypertension, stroke, and heart failure are on the rise, driving demand for interventional cardiology procedures and devices to manage and treat these conditions.

Also, As lifestyles in Asia Pacific become more Westernized, with changes in dietary habits, reduced physical activity, and increased prevalence of risk factors such as obesity, diabetes, and hypertension, the incidence of cardiovascular diseases is escalating. This demographic shift contributes to the rising demand for interventional cardiology interventions and devices in the region.

In addition to this, Asia Pacific is emerging as a popular destination for medical tourism, with countries such as India, Thailand, Singapore, and Malaysia attracting patients from around the world for high-quality, affordable medical care. The availability of state-of-the-art facilities, skilled healthcare professionals, and competitive pricing for interventional cardiology procedures contributes to the region’s growth as a medical tourism hub.

Competitive Landscape

The competitive landscape of the Interventional Cardiology Devices Market is characterized by a dynamic interplay among established multinational corporations, innovative start-ups, and regional players vying for market share and technological leadership. These companies invest heavily in research and development to introduce novel technologies, expand product offerings, and gain regulatory approvals. Additionally, strategic collaborations, mergers, and acquisitions are common strategies employed to enhance market presence, leverage complementary capabilities, and capitalize on emerging trends such as personalized medicine, minimally invasive interventions, and digital health solutions. Regional players, particularly in Asia Pacific, are increasingly gaining traction with their focus on cost-effective solutions, localized innovations, and market expansion initiatives. Overall, the competitive landscape of the Interventional Cardiology Devices Market is characterized by innovation, consolidation, and fierce competition as companies strive to address unmet clinical needs, improve patient outcomes, and sustain growth in a rapidly evolving healthcare landscape.

Some of the prominent players operating in the Interventional Cardiology Devices Market include

Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Johnson & Johnson (Cordis), Braun Melsungen AG, Cook Medical, Cardinal Health, Inc., Biotronik SE & Co. KG, MicroPort Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd., Biosensors International Group, Ltd., Vascular Solutions, Inc. (acquired by Teleflex), Penumbra, Inc., Asahi Intecc Co., Ltd., Teleflex Incorporated, Stryker Corporation, AngioDynamics, Inc., BD (Becton, Dickinson and Company)

Latest Developments

• In December 2022, Boston Scientific Corporation acquired a significant stake in Acotec Scientific Holdings, a Chinese medical technology company offering interventional procedure solutions, thereby expanding its product portfolio and market in China.
• In August 2022, Medtronic has acquired Affera Inc, a leading healthcare technology company, introducing products like the Sphere-9 cardiac diagnostic and ablation catheter and Affera Prism-1 cardiac mapping.

Report Scope

Interventional Cardiology Devices Market, By Category

Product

• Coronary Stents
• Catheters
• Plaque Modification Devices
• Structural Heart Devices
• Angioplasty Stents
• Angioplasty Balloons
• Hemodynamic Flow Alteration Devices

End User

• Hospitals & ASCs
• Catheterization Labs

Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

In case of any please connect with our sales team, who will ensure that your requirements are met.